However, despite these efforts relying on CD133 staining, recent studies indicate that CD133+ tumor cells cannot simply be considered GSCs because not all GSCs express CD133, and subgroups of glioblastoma driven by CD133− GSCs have recently been identified [131, 132]. This evidence concerns the gene PROM1 and glioblastoma.